Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?

Transfus Apher Sci. 2020 Aug;59(4):102858. doi: 10.1016/j.transci.2020.102858. Epub 2020 Jun 27.

Author

Olivier Garraud¹

Affiliation

¹ Faculty of Medicine, EA3064, University of Lyon, Saint-Etienne, France; The National Institute for Blood Transfusion (INTS), Paris, France; Palliative Care Unit, the Ruffec general hospital, Ruffec, France. Electronic address: olivier.garraud@univ-st-etienne.fr.

No abstract available

Keywords: COVID-19; Plasma therapy; clinkical trial; immunotherapy.

MeSH terms

Antibodies, Neutralizing / immunology
Antibodies, Viral / immunology
Betacoronavirus* / physiology
COVID-19
COVID-19 Serotherapy
Clinical Trials as Topic*
Coronavirus Infections / immunology
Coronavirus Infections / therapy*
Evidence-Based Medicine
Humans
Immunization, Passive* / ethics
Immunization, Passive* / methods
Pandemics*
Pneumonia, Viral / immunology
Pneumonia, Viral / therapy*
SARS-CoV-2
Time Factors
Virus Replication

Substances

Antibodies, Neutralizing
Antibodies, Viral